Skip to main content

Advertisement

SpringerLink
Log in

Der Einsatz von Leflunomid bei der rheumatoiden Arthritis

  • BEITRAG ZUM SCHWERPUNKTTHEMA
  • Published:
Zeitschrift für Rheumatologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. American College of Rheumatology-Hotline (2003) FDA Meeting March 2003: Update on the safety of new drugs for rheumatoid arthritis-Part III: Safety and efficacy update on leflunomide (Arava®). www.fda.gov/ohrms/dockets/ac/acmenu.htm

  2. Reinhold-Keller E, Gross WL (2001) Leflunomid zur Behandlung der rheumatoiden Arthritis. Deutsches Ärzteblatt 98:A1881–1887

    Google Scholar 

  3. Bundesausschuß der Ärzte und Krankenkassen (2002) Änderungen der Arzneimittelrichtlinien: Leflunomid. Deutsches Ärzteblatt 99:A 2734

  4. Prakash A, Jarvis B (1999) Leflunomide. Drugs 58:1137–1164

    Google Scholar 

  5. Breedveld FC, Dayer J-M (2000) Leflunomide: mode of action in the treatment of rheumatoid arthritis. Ann Rheum Dis 59:841–849

    Google Scholar 

  6. Mladenovic V, Domljan Z, Rozman B, Jajic I, Mihailovic D, Dordevic J (1995) Safety and effectiveness of leflunomide in the treatment of patients with active rheumatoid arthritis: results of a randomized, placebo-controlled phase II study. Arthritis Rheum 38:1595–1603

    CAS  PubMed  Google Scholar 

  7. Smolen JS, Kalden JR, Scott DL, Rozman B, Kvien TK, Larsen A, Loew-Friedrich I, Oed C, Rosenburg R (1999) Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial. Lancet 353:259–266

    Article  CAS  PubMed  Google Scholar 

  8. Scott DL, Smolen JS, Kalden JR, van de Putte LBA, Larsen A, Kvien TK, Schattenkirchner M, Nash P, Oed C, Loew-Friedrich I (2001) Treatment of active rheumatoid arthritis with leflunomide: two year follow up of a double blind, placebo contolled trial versus sulfasalazine. Ann Rheum Dis 60:913–923

    Article  CAS  PubMed  Google Scholar 

  9. Strand V, Cohen S, Schiff M, Weaver A, Fleischmann R, Cannon G, Fox R, Moreland L, Olsen N, Furst D, Caldwell J, Kaine J, Sharp J, Hurley F, Loew-Friedrich I (1999) Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med 159:2542–2550

    Article  CAS  PubMed  Google Scholar 

  10. Cohen S, Cannon GW, Schiff M, Weaver A, Fox R, Olsen N, Furst D, Sharp J, Moreland L, Caldwell J, Kaine J, Strand V (2001) Two-year, blinded, randomized, controlled trial of treatment of active rheumatoid arthritis with leflunomide compared with methotrexate. Arthritis Rheum 44:1984–1992

    Google Scholar 

  11. Emery P, Breedveld FC, Lemmel EM, Kaltwasser JP, Dawes PT, Gomor B, Van Den Bosch F, Nordstrom D, Bjorneboe O, Dahl R, Horslev-Petersen K, Rodriguez De La Serna A, Molloy M, Tikly M, Oed C, Rosenburg R, Loew-Friedrich I (2000) A comparison of the efficacy and safety of leflunomide and methotrexate for the treatment of rheumatoid arthritis. Rheumatology 39:655–665

    Article  CAS  PubMed  Google Scholar 

  12. Kalden JR, Scott DL, Smolen JS, Schattenkirchner M, Rozman B, Williams BD, Kvien TK, Jones P, Williams RB, Oed C, Rosenburg R (2001) Improved functional ability in patients with rheumatoid arthritis—longterm treatment with leflunomide versus sulfasalazine. J Rheumatol 28:1983–1991

    Google Scholar 

  13. Sharp JT, Strand V, Leunh H, Hurley F, Loew-Friedrich I (2000) Treatment with leflunomide slows radiographic progression of rheumatoid arthritis. Results from three randomized controlled trials of leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 43:495–505

    Google Scholar 

  14. Larsen A, Kvien TK, Schattenkirchner M et al (2001) Slowing of disease progression in rheumatoid arthritis patients during long-term treatment with leflunomide or sulfasalazine. Scand J Rheumatol 30:135–142

    Article  CAS  PubMed  Google Scholar 

  15. Furst DE, Cohen S, Emery P, Dorrier K, Simpson K (2001) Does folic acid decrease the efficacy as well as the toxicity of methotrexate in rheumatoid arthritis? Arthritis Rheum 44, Suppl, Abstract 1921

  16. Kalden JR, Schattenkirchner M, Sörensen H, Emery P, Deighton C, Rozman B, Breedveld F (2003) Efficacy and safety of leflunomide in patients with active rheumatoid arthritis—five years follow-up. Arthritis Rheum 46:1513–1520

    Google Scholar 

  17. Weinblatt ME, Kremer JM, Coblyn JS, Maier AL, Helfgott SM, Morrell M (1999) Pharmakokinetics, safety and efficacy of combination treatment with methotrexate and leflunomide in patients with active rheumatoid arthritis. Arthritis Rheum 42:1322–1328

    Article  CAS  PubMed  Google Scholar 

  18. Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Weisman MH, Bensen WM, Kaine JL, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Waltuck J, Lindsley HB, Markenson JA, Strand V, Crawford B, Fernando I, Simpson K, Bathon JM (2002) Concomitant leflunomide therapy in patients with active rheumatoid arthritis despite stable doses of methotrexate. Ann Intern Med 137:726–733

    Google Scholar 

  19. Kremer JM, Genovese MC, Cannon GW, Caldwell JR, Cush JJ, Furst DE, Luggen ME, Keystone E, Bathon JM, Kavanaugh A, Ruderman EM, Coleman P, Curtis DL, Kopp EJ, Kantor SM, Weisman M, Waltuck J, Lindsley HB, Markenson JA, Crawford B, Fernando I, Simpson K, Strand V (2004) Combination leflunomide and methotrexate (MTX) therapy for patients with active rheumatoid arthritis failing MTX monotherapy: Open-label extension of a randomized, double-blind, placebo controlled trial. J Rheumatol 31:1521–1531

    Google Scholar 

  20. Fachinformation Arava, Stand Oktober 2003

Download references

Author information

Authors and Affiliations

  1. Praxiszentrum St. Bonifatius, St.-Bonifatius-Str. 5, 81541, München, Germany

    K. Krüger

  2. Rheumatologie, Klaus-Miehlke-Klinik, Leibnizstr. 23, 65191, Wiesbaden, Germany

    W. Bolten

Authors
  1. K. Krüger
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Bolten
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to K. Krüger.

Additional information

und die Kommission Pharmakotherapie der DGRh

Rights and permissions

Reprints and permissions

About this article

Cite this article

Krüger, K., Bolten, W. Der Einsatz von Leflunomid bei der rheumatoiden Arthritis. Z. Rheumatol. 64, 96–101 (2005). https://doi.org/10.1007/s00393-005-0694-8

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00393-005-0694-8

Search

Navigation